{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4250"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4250","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"INTEGRATED COMPUTATIONAL APPROACHES: ELUCIDATING MOLECULAR MECHANISMS OF PATHOGENIC PROTEINS AND DESIGNING NOVEL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS AND SARS-COV-2","abstract":"Chapter 1 introduces computational strategies in computer aided drug design (CADD), focusing on physics-based methodologies to enhance drug discovery. This chapter also discusses the theoretical foundations and practical applications of molecular dynamics (MD) simulations including free energy and stochastic kinetic analysis. In Chapter 2, CADD methods lead to development of inhibitors targeting the RNA Dependent RNA Polymerase (RdRP) of SARS-CoV-2. Inspired by the nucleotide inhibitor Molnupiravir, we aim to design a combinatorial library of 72 novel inhibitors capable of impeding a dual threat inhibition mechanism inducing lethal mutations along with stalling viral replication with specific selectivity to RdRp over Human Polymerase II. In Chapter 3, we concentrate on the characterization of MmpL3, a crucial Resistance Nodulation Division (RND) transporter in MtB. Through molecular dynamics simulations, we gain a comprehensive understanding of MmpL3's structural dynamics and conformational functionality. A significant aspect of this chapter involves investigating the inhibition mechanism of SQ109, an Anti-tuberculosis drug, with a specific focus on understanding it’s the conformational states of MmpL3 and allosteric inhibition effects induced by SQ109.","abstract_html":"Chapter 1 introduces computational strategies in computer aided drug design (CADD), focusing on physics-based methodologies to enhance drug discovery. This chapter also discusses the theoretical foundations and practical applications of molecular dynamics (MD) simulations including free energy and stochastic kinetic analysis. In Chapter 2, CADD methods lead to development of inhibitors targeting the RNA Dependent RNA Polymerase (RdRP) of SARS-CoV-2. Inspired by the nucleotide inhibitor Molnupiravir, we aim to design a combinatorial library of 72 novel inhibitors capable of impeding a dual threat inhibition mechanism inducing lethal mutations along with stalling viral replication with specific selectivity to RdRp over Human Polymerase II. In Chapter 3, we concentrate on the characterization of MmpL3, a crucial Resistance Nodulation Division (RND) transporter in MtB. Through molecular dynamics simulations, we gain a comprehensive understanding of MmpL3&#x27;s structural dynamics and conformational functionality. A significant aspect of this chapter involves investigating the inhibition mechanism of SQ109, an Anti-tuberculosis drug, with a specific focus on understanding it’s the conformational states of MmpL3 and allosteric inhibition effects induced by SQ109.","abstract_has_math":false,"creators":["Carbone, Justin David"],"institution":null,"degree_name":"Master of Science (M.S.) in Pharmaceutical Science","degree_level":"Thesis","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Chun Wu, Ph.D.","Gregory A. Caputo Ph. D.","Kandalam V. Ramanujachary Ph. D"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:46Z","subjects":["Biochemistry; Biophysics; Computer aided drug design; Molecular Dynamics; Molecular mechanics; Protein kinetics","Drugs--Design","Medicinal-Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3244","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3244","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4250","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Chun Wu, Ph.D.","Gregory A. Caputo Ph. D.","Kandalam V. Ramanujachary Ph. D"]},{"key":"dc:creator","label":"Author","values":["Carbone, Justin David"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-06-13T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-06-13T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.) in Pharmaceutical Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry; Biophysics; Computer aided drug design; Molecular Dynamics; Molecular mechanics; Protein kinetics","Drugs--Design","Medicinal-Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3244"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Chapter 1 introduces computational strategies in computer aided drug design (CADD), focusing on physics-based methodologies to enhance drug discovery. This chapter also discusses the theoretical foundations and practical applications of molecular dynamics (MD) simulations including free energy and stochastic kinetic analysis. In Chapter 2, CADD methods lead to development of inhibitors targeting the RNA Dependent RNA Polymerase (RdRP) of SARS-CoV-2. Inspired by the nucleotide inhibitor Molnupiravir, we aim to design a combinatorial library of 72 novel inhibitors capable of impeding a dual threat inhibition mechanism inducing lethal mutations along with stalling viral replication with specific selectivity to RdRp over Human Polymerase II. In Chapter 3, we concentrate on the characterization of MmpL3, a crucial Resistance Nodulation Division (RND) transporter in MtB. Through molecular dynamics simulations, we gain a comprehensive understanding of MmpL3's structural dynamics and conformational functionality. A significant aspect of this chapter involves investigating the inhibition mechanism of SQ109, an Anti-tuberculosis drug, with a specific focus on understanding it’s the conformational states of MmpL3 and allosteric inhibition effects induced by SQ109."]},{"key":"dc:title","label":"Title","values":["INTEGRATED COMPUTATIONAL APPROACHES: ELUCIDATING MOLECULAR MECHANISMS OF PATHOGENIC PROTEINS AND DESIGNING NOVEL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS AND SARS-COV-2"]}]}],"canonical_facts":{"dc:contributor":["Chun Wu, Ph.D.","Gregory A. Caputo Ph. D.","Kandalam V. Ramanujachary Ph. D"],"dc:creator":["Carbone, Justin David"],"dc:date.available":["2025-06-13T07:00:00Z"],"dc:date.created":["2024-06-13T07:00:00Z"],"dc:description.abstract":["Chapter 1 introduces computational strategies in computer aided drug design (CADD), focusing on physics-based methodologies to enhance drug discovery. This chapter also discusses the theoretical foundations and practical applications of molecular dynamics (MD) simulations including free energy and stochastic kinetic analysis. In Chapter 2, CADD methods lead to development of inhibitors targeting the RNA Dependent RNA Polymerase (RdRP) of SARS-CoV-2. Inspired by the nucleotide inhibitor Molnupiravir, we aim to design a combinatorial library of 72 novel inhibitors capable of impeding a dual threat inhibition mechanism inducing lethal mutations along with stalling viral replication with specific selectivity to RdRp over Human Polymerase II. In Chapter 3, we concentrate on the characterization of MmpL3, a crucial Resistance Nodulation Division (RND) transporter in MtB. Through molecular dynamics simulations, we gain a comprehensive understanding of MmpL3's structural dynamics and conformational functionality. A significant aspect of this chapter involves investigating the inhibition mechanism of SQ109, an Anti-tuberculosis drug, with a specific focus on understanding it’s the conformational states of MmpL3 and allosteric inhibition effects induced by SQ109."],"dc:identifier":["https://rdw.rowan.edu/etd/3244"],"dc:subject":["Biochemistry; Biophysics; Computer aided drug design; Molecular Dynamics; Molecular mechanics; Protein kinetics","Drugs--Design","Medicinal-Pharmaceutical Chemistry","Pharmacy and Pharmaceutical Sciences"],"dc:title":["INTEGRATED COMPUTATIONAL APPROACHES: ELUCIDATING MOLECULAR MECHANISMS OF PATHOGENIC PROTEINS AND DESIGNING NOVEL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS AND SARS-COV-2"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (M.S.) in Pharmaceutical Science"]},"updated_at":"2026-11-19T08:59:46Z"}